IgG-based elimination diet, obesity and the microbiome – new research findings
In this article
  1. IgG ELISA-based elimination diet in irritable bowel syndrome – a randomised, double-blind, sham diet-controlled study
  2. Salt substitution, recurrent stroke and mortality – a randomised clinical trial
  3. An omnivorous and a high-protein vegan diet improve peripheral insulin sensitivity to a similar extent in patients with T2DM
  4. Nutrient-stimulated hormone-based therapy – nutritional and functional outcomes
  5. The effect of a plant-based, sustainable diet on obesity –
  6. a systematic review
  7. Consumption of ultra-processed foods and the development of obesity in children
  8. A global assessment of current trends in gastrointestinal cancers and lifestyle-associated risk factors
  9. The effect on performance of anthocyanin-rich blackcurrant as an ergogenic aid to physical performance
  10. The cardiometabolic benefits of a non-industrialised diet are mediated through modulation of the gut microbiome
  11. Choline supplementation – an update

Author: Dr Károly Krkos

IgG ELISA-based elimination diet in irritable bowel syndrome – a randomised, double-blind, sham diet-controlled study

Irritable bowel syndrome affects 4–9% of the human population. Its negative effects (reduced capacity to work, low quality of life) are significant. Around 90% of patients report an improvement in their condition as a result of dietary change. The low FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols) diet, whose effect is scientifically proven and which significantly reduces abdominal pain and bloating, is effective in about 50–60% of patients, but it is time-consuming, difficult to follow and costly, and it cannot be determined before the diet for whom this dietary change will be effective. This is why the possibility of developing a personalised diet arose. In putting together an individual diet, IgG antibodies produced against the food components consumed help to select the foods to be eliminated. A diet based on IgG antibody-guided elimination is a potential option for individualised dietary change. Previous studies based on such diets, however, have been burdened with methodological problems. This study aims to reliably assess the usefulness of the selected IgG assay for setting up an elimination diet.

You can read more about the possible causes of weight problems, and whether food sensitivity may play a part, on our weight problems page.

Eight centres took part in this randomised, double-blind, sham diet-controlled study. Patients with IBS were studied who were IgG-positive to at least one food (out of 18) and whose abdominal pain intensity score was between 3 and 7.5 (on an 11-point scale) during the two-week screening period. Participants were randomised to either the IgG-based elimination group or the sham diet group, which was maintained for 8 weeks. The primary endpoint was a reduction in abdominal pain intensity of at least 30%, lasting at least 2 weeks, in the last 4 weeks. Of the 238 IBS patients enrolled, 223 were included in the analysis. A significantly greater proportion of the elimination diet group reached the primary endpoint than of the sham diet group. Subgroup analysis showed that in the constipation-predominant and mixed bowel habit groups, a greater proportion of those on the elimination diet reached the primary endpoint than of those on the sham diet.

P Singh, W D Chey et al.: Gastroenterology 2025, https://doi.org/10.1053/j.gastro.2025.01.223

Salt substitution, recurrent stroke and mortality – a randomised clinical trial

Stroke is a condition associated with long-term disability and is also a leading cause of death, especially in low- and middle-income countries. Among the risk factors for the disease, the high prevalence of hypertension plays a prominent role. Randomised clinical trials have shown that reducing the sodium chloride content of salt and replacing it with potassium chloride lowers blood pressure. According to a meta-analysis of more than 20 studies, substituting salt with potassium salt results in a long-term reduction in blood pressure in various populations, and its favourable effect on the course of cardiovascular disease is also well known; however, the direct effect of salt substitution on stroke risk and mortality has not been studied so far.

The Salt Substitute and Stroke Study (SSaSS), in which salt substitution lasted 4.75 years, provided direct evidence of a reduction in stroke risk, cardiovascular events and premature death, based on the data of 20,995 participants. Residents of 600 villages in northern China were enrolled in the study. Participants used either salt containing 25% potassium chloride (and 75% sodium chloride) or conventional salt. The primary endpoint was recurrent stroke.

The evaluation included 15,249 patients who had had a stroke, of whom 2,735 had a further stroke (691 with a fatal outcome) and 3,242 deaths occurred. The rate of recurrent stroke was significantly lower among those using the substitute salt (P=0.005; in patients with haemorrhagic stroke the difference was even greater, P=0.002), and the total mortality rate was also lower (P=0.003).

X Dink, X Zhang et al: JAMA Cardiology 2025, https://doi.org/10.1001/jamacardio.2024.5417

An omnivorous and a high-protein vegan diet improve peripheral insulin sensitivity to a similar extent in patients with T2DM

Dietary intervention is an important modifying factor in the treatment of type 2 diabetes (T2D). Dietary change aimed at a calorie deficit is one of the important factors in achieving weight loss. Although there is no consensus on the optimal macronutrient composition, according to many studies a high-protein diet results in improved glycaemic control.

Mycoprotein is a food ingredient high in fibre and protein that has already been shown to improve acute glycaemic control. The study examined whether mycoprotein included in a high-protein vegan diet improves glycaemic control to a greater extent than an omnivorous diet with the same nitrogen content.

Patients with T2D aged 40–70 years were enrolled in the study, whose HbA1c level was above mmol/mol and whose BMI was between 27 and 45 kg/m2. Those receiving treatment with insulin, sulphonylureas or anti-obesity medication, those who had lost more than 5 kg in the 6 months before enrolment, those with an eGFR below 30 mL/min, and those who had heart failure, had had a heart attack or were pregnant were excluded. During the study, patients followed for 5 weeks an isocaloric, high-protein diet of the same nitrogen content, either vegan and enriched with mycoprotein, or omnivorous. Insulin sensitivity was measured with the hyperinsulinaemic-euglycaemic clamp method with continuous glucose monitoring.

Peripheral insulin sensitivity improved in both the vegan and the omnivorous groups, but there was no significant difference in the extent of this improvement between the two groups.

G Whelehan, M L Dirks et al: Diabetes, Obesity& Metabolism 2025, https://doi.org/10.111/dom.16100

Nutrient-stimulated hormone-based therapy – nutritional and functional outcomes

Obesity is a chronic disease which in the long term leads to the development of comorbid conditions and increased mortality, and it is often accompanied by altered nutritional status, nutrient deficiency, a decline in skeletal muscle mass and function, and disability. The treatment options for obesity (lifestyle change, medication, weight-loss surgery) result in weight loss to varying degrees. The introduction of nutrient-stimulated hormone-based therapies (NuSHs) has brought a significant improvement in treatment and has also reduced the development of certain comorbid conditions. The new agents – such as glucagon-like peptide-1 receptor agonists (GLP1-RA), dual hormone agonists [GLP1-amylin, GLP1-glucose-dependent insulinotropic polypeptide (GIP)] and triple hormone agonists (GLP1-GIP-glucagon) – result in weight loss of more than 10%, and their effectiveness matches that of weight-loss surgery.

Many review articles discuss how weight loss is associated with significant muscle loss and an inadequate intake of micronutrients and high-quality protein. The analysis of these phenomena in the studies mentioned is unsatisfactory. The article set out to map those data of the studies registered on ClinicalTrials.gov and the International Clinical Trials Registry Platform (ICTRP) (up to and including 31 December 2023) that point to the nutritional and functional effects of the therapy. Non-randomised or quasi-randomised studies, phase I studies, studies that did not include weight-loss data, studies in which the intervention lasted less than 6 months, and studies that did not include the BMI threshold accepted as a satisfactory criterion were excluded. The following parameters were evaluated: dietary composition, eating habits, body composition, physical performance, muscle strength, bone health; and levels of vitamins, trace elements, albumin, prealbumin and haemoglobin.

Of the 417 studies used in the analysis, 20.4% addressed body composition, 17.3% albumin/prealbumin/haemoglobin levels and 17% diet and eating habits. Bone health, physical performance, muscle strength and the measurement of vitamins/trace elements featured in fewer than 5% of the reports.

S Czernichow, N Rassy et al: Obesity Reviews 2024, https://doi.org/10.1111/obr.13890

The effect of a plant-based, sustainable diet on obesity –

a systematic review

The double crisis (climate change and obesity) poses a significant threat worldwide to health and to environmental sustainability. The food supply system has a significant impact on the environment (land use, livestock emissions, deforestation, food waste). Dietary sustainability presupposes taking into account the environmental impact of food production, distribution and consumption. Animal products mean more greenhouse gas emissions than plant products, and a plant-based diet means reduced emissions. One review on sustainable diets (the EAT-Lancet model, W. Willett, J Rockström et al: Lancet 2019, https://doi.org/10.1016/S0140-6736(18)31788-4) gives priority to the consumption of plant foods, adapted to regional eating habits. These diets are both environmentally friendly and health-promoting (just think of tackling obesity and chronic diseases). Curbing obesity requires a holistic strategy that targets not only individual health maintenance but also brings a sustainable solution for reducing the negative effects of the food supply system on nature. This systematic review examines the relationship between obesity and plant-based diets, focusing on studies analysing BMI and body fat content. Although only a small number of such studies are available, it is becoming evident that a plant-based – especially a healthy plant-based – diet reduces the prevalence of obesity.

S P Mambrini, C Pewnzavecchia et al.: Obesity Reviews 2024, https://doi.org/10.1111/obr.13901

Consumption of ultra-processed foods and the development of obesity in children

Consumption of ultra-processed foods (UPF) is rising worldwide. UPF manufacturing, emulsifiers and added additives lead to long-life foods, most of which are energy-dense and nutritionally unbalanced (e.g. high in added sugar, saturated fats and salt). For years they have become increasingly widespread in retail, and their consumption is growing. According to a survey carried out in 2015, in Canada 50% of the daily energy intake of children and adolescents comes from UPF, which represents a significant health risk. Diet is a modifiable risk factor and an important factor in reducing chronic disease. In parallel with the rise in UPF consumption, the proportion of people with obesity is constantly increasing (in Canada, 26.8% of the population had obesity in 2018, and 28.2% two years later). In 2023, a third of Canadian children and young adults were found to be overweight, boys in a higher proportion.

For the CHILD study, children born healthy between June 2009 and April 2012 after a pregnancy longer than 34 weeks and 4 days were studied. At the age of 3 (between 2011 and 2016), their dietary data were recorded (2,411 children). At the age of 5, the children's BMI, waist-to-height ratio, and subscapular and triceps skinfold thickness were recorded (between 2013 and 2018, 2,217 patients).

Dietary data were assessed with a semi-quantitative food frequency questionnaire (FFQ). The degree of food processing was divided into 4 groups according to the NOVA classification system: 1. unprocessed and minimally processed foods; 2. processed culinary ingredients; 3. processed foods; 4. UPF; the percentage of energy intake derived from UPF was then calculated.

At the age of 3, 45% of the children's energy intake came from UPF. Energy intake from group 1 (unprocessed and minimally processed) foods was 37.5%. According to the anthropometric data recorded at the age of 5, overweight was more common among boys who consumed a higher proportion of UPF. No significant association was found among girls.

Z H Chen, S Mousavi et al: JAMA Network Open 2025, https://doi.org/10.1001/jamanetworkopen.2024.57341

In 2018, gastrointestinal cancers accounted for 26.3% of carcinoma cases and 35.4% of cancer deaths in the world's population. This study analyses the incidence, prevalence, mortality and risk factors of this group of diseases and, within it, of the 6 main tumour types [oesophageal cancer (EC), gastric cancer (GC), liver cancer (LC), pancreatic cancer (PC), colorectal cancer (CRC)]. The starting point was the information available in the Global Cancer Observatory and Global Health Observatory databases. By comparing incidence, prevalence and mortality with the Human Development Index (HDI) of individual nations, the risk factors and the age- and sex-related trends were identified.

In 2020, the age-standardised incidence rate, in line with mortality, was as follows: in Asia LC, EC and GC, and in Europe CRC and PC were the most common GI tumours. Incidence and mortality correlated positively, and the mortality-to-incidence ratio (MIR) negatively, with national HDI. The high MIR observed in developing countries can probably be explained by a lack of prevention and effective treatment. GI prevalence was highest in Europe and correlated positively with lifestyle-related risk factors (alcohol consumption, smoking, obesity, insufficient physical activity, high cholesterol), but negatively with high blood pressure and diabetes. The incidence of EC is steadily decreasing, and that of GC follows a similar pattern, whereas the incidence of CRC is increasing in most countries/regions, especially in the younger generation. The incidence of LC and PC is also increasing in most age groups, except among young men. Mortality from EC, GC and CRC is decreasing in most countries/regions. For PC and LC an age-related trend was observed: decreasing in the young population and increasing in the older generation.

In general, the increasing frequency of GI cancers could be explained by risk factors associated with the Western lifestyle in countries with high and very high HDI. Stronger prevention of GI cancers and improved treatment methods – especially in the case of comorbid metabolic diseases – are important in reducing this group of diseases.

L Lu, C S Mullins et al: Cancer Communications 2021, https://doi.org/10.1002/cac2.12220

The effect on performance of anthocyanin-rich blackcurrant as an ergogenic aid to physical performance

Active athletes often take dietary supplements to boost their competitive performance and fitness. The study of polyphenols is a popular area of sports medicine, as these compounds improve athletic performance and enhance fitness. Anthocyanins are polyphenols found in significant amounts in dark, coloured plants and berries. Their main beneficial properties are their antioxidant and anti-inflammatory effects. The article summarises the effect of anthocyanin-rich blackcurrant extract on whole-body physical performance and recovery, based on 17 randomised, placebo-controlled crossover studies and 1 placebo-controlled, parallel-group study. Ten studies focused on the performance-enhancing effect and 8 on recovery. Of the studies examining performance enhancement, 6 reported a positive effect, 3 could not show a significant effect and 1 ended with mixed results. Of the studies focusing on recovery, 7 reported a positive effect, 1 showed no change and 1 showed a deterioration. In the studies, 105–315 mg of anthocyanins a day were taken for 7 days, and performance in various tasks (rowing, cycling, running) was examined. Knowledge of the effects of anthocyanins (on metabolism and cell function) is incomplete, and further analyses are needed.

M E T Willems, S D Blacker et al: Current Development in Nutrition 2025, https://doi.org/10.1016/j.cdnut.2024.104523

The cardiometabolic benefits of a non-industrialised diet are mediated through modulation of the gut microbiome

Industrialisation has an unfavourable effect on the microbiome and creates the conditions for chronic non-communicable diseases to develop. In a randomised controlled study in healthy Canadian adults, the effects of a non-industrialised diet (the restore diet) and of Limosilactobacillus reuteri, which is rarely found in people eating industrialised food, were examined. Although the restore diet reduced microbiome diversity, it enhanced the persistence of the L. reuteri strain (PB-W1) originating from rural Papua New Guinea and restored several features of the microbiome that had been altered by industrialisation. The diet changed the composition of microbiota-derived plasma metabolites in a favourable direction. Several cardiometabolic benefits came from the administration of L. reuteri and several from the microbiome changes brought about by the diet. The result shows that a dietary intervention aimed at restoring the gut microbiome can improve host–microbiome interactions and supports the application of appropriate dietary recommendations.

F Li, A M Armet et al: Cell 2025, https://doi.org/10.1016/j.cell.2024.12.034

Choline supplementation – an update

This study evaluates the effects of the choline supplements currently available [choline alfoscerate, also known as α-glycerophosphorylcholine (αGPC), choline bitartrate, lecithin, citicoline)] on the basis of clinical and preclinical studies. Choline is a widely used dietary supplement, recommended for improving memory and strengthening cognitive functions.

Choline is a nutrient essential for the functioning of the liver, muscles and brain, a component of the membranes of cells and their organelles, and it plays a fundamental role in many physiological processes (signal transduction, DNA and histone methylation, myelination of nerves). Choline is the precursor of various metabolites (e.g. the neurotransmitter acetylcholine, membrane phospholipids, phosphatidylcholine, sphingomyelin, and the methyl donor betaine). Choline is found in foods, and its de novo synthesis takes place via the methylation of phosphatidylethanolamine, producing phosphatidylcholine. The body's need for choline increases during pregnancy (placental function, foetal growth, brain development), and a deficiency can lead to premature birth and hepatic steatosis.

The article discusses in more detail the relationship between choline and endothelial function, choline and cardiometabolic disorders, and choline and cognitive function.

U Kansakar, V Trimarco et al: Frontiers in Endocrinology 2023, https://doi.org/10.3389/fendo.2023.1148166

Book a food intolerance test

Food intolerance

Don't just get the school bag ready

Starting school is not only about new exercise books and a changed daily routine but also about reorganising family meals. The FOODTEST Children's pac...

Related articles